Pages that link to "Q33475641"

The following pages link to Prostacyclin administration during cardiopulmonary bypass in man. (Q33475641):

Displaying 39 items.

• Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man (Q28367756) (← links)
• Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia (Q32110828) (← links)
• Prostacyclin (PGI2) (Q33477268) (← links)
• Effect of intracardiac repair on biosynthesis of thromboxane A2 and prostacyclin in children with a left to right shunt (Q33614342) (← links)
• Effect of prostacyclin (PGI2) on water and solute transport in the human jejunum (Q34528482) (← links)
• Adventures and excursions in bioassay—the stepping stones to prostacyclin (Q36705201) (← links)
• Prostaglandins and the cardiovascular system (Q40147394) (← links)
• Nobel lecture, 8th December 1982. Adventures and excursions in bioassay: the stepping stones to prostacyclin (Q40165649) (← links)
• Antithrombotic assessment and clinical potential of prostacyclin analogues. (Q40204869) (← links)
• Prostaglandins and anaesthesia (Q40206038) (← links)
• Prostacyclin: a review of current clinical experience (Q40247697) (← links)
• A prospective study of the clinical benefits of prostacyclin in 554 cardiopulmonary bypass procedures. (Q40485191) (← links)
• Pharmacodynamic profile of prostacyclin (Q40581672) (← links)
• Prostaglandins and related substances (Q40844424) (← links)
• Extracorporeal Left Ventricular Assistance with Prostacyclin and Heparinized Centrifugal Pump (Q41562209) (← links)
• In vivo interaction of prostacyclin with an inhibitor of cyclic nucleotide phosphodiesterase, HL 725 (Q41740217) (← links)
• Quantification of extracorporeal platelet deposition in cardiopulmonary bypass: effects of ZK 36374, a prostacyclin analogue (Q44832844) (← links)
• Evidence suggestive of diffuse brain damage following cardiac operations (Q48683125) (← links)
• Earlier charcoal haemoperfusion in fulminant hepatic failure (Q48895106) (← links)
• Effects of prostacyclin on myocardial hemodynamics and metabolism after coronary artery bypass grafting (Q51560827) (← links)
• A comparison of prostacyclin and sodium nitroprusside for the treatment of heart failure after cardiac surgery (Q51586589) (← links)
• Prostacyclin as vasodilator in anaesthesia and intensive care (Q51866632) (← links)
• Conjugated Estrogens Reduce Endothelial Prostacyclin Production and Fail to Reduce Postbypass Blood Loss (Q54078711) (← links)
• Platelet protective effect of TAK-029, a novel glycoprotein IIb/IIIa antagonist: an in vitro study. (Q54288875) (← links)
• Effects of taprostene, a stable prostacyclin analogue, on haemodynamics, platelet function and arachidonate metabolism in healthy volunteers (Q67293250) (← links)
• Platelet damage by protamine and the protective effect of prostacyclin: an experimental study in dogs (Q68893478) (← links)
• Effects of prostacyclin infusion on renal function during cardiopulmonary bypass (Q69952801) (← links)
• The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers (Q70177471) (← links)
• The effect of prostacyclin on cerebral vasospasm. An experimental study (Q70250823) (← links)
• Prostacyclin (Q70252002) (← links)
• Binding and inactivation of prostacyclin (PGI2) by human erythrocytes (Q70255145) (← links)
• Effects of prostacyclin and indomethacin on experimental delayed cerebral vasospasm (Q70283392) (← links)
• Does prostacyclin prevent cognitive deficits after open heart surgery? (Q70334879) (← links)
• Disadvantages of prostacyclin infusion during cardiopulmonary bypass: a double-blind study of 50 patients having coronary revascularization (Q70393591) (← links)
• Low-dose Iloprost infusion improves insulin action and non-oxidative glucose metabolism in hypertensive patients (Q71103657) (← links)
• Prostacyclin counteracts the increase in capillary permeability induced by tumour necrosis factor-alpha (Q71952429) (← links)
• Thromboxane synthase inhibition in patients with atherosclerotic heart disease (Q72482829) (← links)
• Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of β-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1α and heparin (Q72721326) (← links)
• Effects of Prostacyclin Infusion on Platelet Activation and Postoperative Blood Loss in Coronary Bypass (Q72787101) (← links)